IMW 2021 | The IMW 2021 congress and COVID-19
Heinz Ludwig and Hermann Einsele
• 9 Sep 2021
Heinz Ludwig, MD, of the Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria, and Hermann Einsele, MD, FRCP, of the University of Würzburg, Würzburg, Germany, discuss the impact of the COVID-19 pandemic on the 18th International Myeloma Workshop (IMW). This interview took place during the IMW 2021 congress.
Disclosures
Heinz Ludwig, MD, has received research funding from Amgen and Takeda; and has received speaker’s honoraria and has participated in advisory boards for Amgen, Takeda, Sanofi, Janssen, Celgene-BMS and Seattle Genetics.
